CD44v6 expression in tissue of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Expression of mRNA encoding IL-8 and CXCR‘s in blood and lavage of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Expression of MAGE in the induced sputum of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002
Chemokine mRNA expression profiling in pulmonary sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008
Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
The expression rate of hTERT mRNA of bronchial washing in lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 388s Year: 2006
Expression of CD163 in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 477s Year: 2003
Evaluation expression of miR-146a and miR-155 and inflammatory cytokines in blood of non-small cell lung cancer patients Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004
Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009
Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Expression of survivin and p53 protein in pulmonary tumours Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Increased expression of MMP-2 in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005
Lebrikizumab reduces serum periostin in asthma patients with elevated baseline periostin Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012
Cytoplasmic expression of p21CIP1/WAF1 is increased in endoalveolar macrophages of smokers Source: Eur Respir J 2002; 20: Suppl. 38, 417s Year: 2002
Downregulation of the pro-apototic gene, BNIPL, in bronchial biopsies from COPD patients Source: ERS Lung Science Conference 2017 Year: 2017
Distribution and mRNA expression of tenascin-C in developing human lung Source: Eur Respir J 2001; 18: Suppl. 33, 244s Year: 2001